RecruitingPhase 2NCT06954766
Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981
A Randomized, Double-blind, Sham-controlled, Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981 in Patients With Degenerative Knee Osteoarthritis
Sponsor
Chong Kun Dang Pharmaceutical
Enrollment
100 participants
Start Date
May 12, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to prove that the temporary symptom improvement effect on knee osteoarthritis using CKD-981
Eligibility
Min Age: 40 YearsMax Age: 80 Years
Inclusion Criteria4
- Patients between 40 years and 80 years old
- Patients who have experiencing knee pain more than 8 weeks
- VAS more than 40 mm
- Kellgren and Lawrence grade 2 and 3 in X' ray knee joint
Exclusion Criteria4
- Previous knee surgery in affected side
- Patients with Rheumatoid arthritis, connective tissue disease, Paget's disease
- Infection of knee joint
- BMI more than 35kg/m2
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICECKD-981(1)
20 minutes per day, 5 days a week for 6 weeks.
DEVICECKD-981(2)
20 minutes per day, 5 days a week for 6 weeks.
DEVICESham device
20 minutes per day, 5 days a week for 6 weeks.
DRUGReference Drug
QD for 6 weeks
DRUGPlacebo Drug
QD for 6 weeks
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06954766
Related Trials
Innovations in Genicular Outcomes Registry
NCT0549533419 locations
Artificial Intelligence-Assisted Advanced Analysis of Knee Imaging and Outcome Prediction
NCT077211161 location
Comparison of Aquatic and Land-Based Mulligan Mobilization With Movement in Knee Osteoarthritis
NCT074845291 location
Integrated Trunk Stabilization With Osteoarthritis Rehabilitation in Knee-Spine Syndrome
NCT074845942 locations
The personalKNEE Trial
NCT065070461 location